Literature DB >> 32895754

Revealing the true face behind the mask of ALK-positive anaplastic large cell lymphoma (ALCL).

Hannah Eisfeld1, Stefan Kircher2, Andreas Rosenwald2, Ioannis Anagnostopoulos2, Mathias Werner3, Nikolaus Gaßler4, Gunter Wolf5, Lukas Lehmkuhl6, Ulf Teichgräber7, Falk Gühne8, Andreas Darr8, Martin Freesmeyer8, Wolfram Weschenfelder9, Gunther Hofmann9, Ramazan Dalkilic10, Rolf Kalff10, Andreas Hochhaus1, Karin G Schrenk11.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32895754      PMCID： PMC7960597          DOI： 10.1007/s00277-020-04247-4

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  9 in total

Review 1.  CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features.

Authors:  H Stein; H D Foss; H Dürkop; T Marafioti; G Delsol; K Pulford; S Pileri; B Falini
Journal:  Blood       Date:  2000-12-01       Impact factor: 22.113

Review 2.  Anaplastic large cell lymphoma: pathology, genetics, and clinical aspects.

Authors:  Naoko Tsuyama; Kana Sakamoto; Seiji Sakata; Akito Dobashi; Kengo Takeuchi
Journal:  J Clin Exp Hematop       Date:  2017

3.  ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin's lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK)

Authors:  S W Morris; C Naeve; P Mathew; P L James; M N Kirstein; X Cui; D P Witte
Journal:  Oncogene       Date:  1997-05-08       Impact factor: 9.867

Review 4.  Nucleophosmin-anaplastic lymphoma kinase: the ultimate oncogene and therapeutic target.

Authors:  Michael T Werner; Chen Zhao; Qian Zhang; Mariusz A Wasik
Journal:  Blood       Date:  2016-11-22       Impact factor: 22.113

Review 5.  Update on the Treatment of Anaplastic Large Cell Lymphoma.

Authors:  Khoan Vu; Weiyun Ai
Journal:  Curr Hematol Malig Rep       Date:  2018-04       Impact factor: 3.952

Review 6.  The biology and management of systemic anaplastic large cell lymphoma.

Authors:  Greg Hapgood; Kerry J Savage
Journal:  Blood       Date:  2015-04-13       Impact factor: 22.113

7.  International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes.

Authors:  Julie Vose; James Armitage; Dennis Weisenburger
Journal:  J Clin Oncol       Date:  2008-07-14       Impact factor: 44.544

8.  The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells.

Authors:  H Stein; D Y Mason; J Gerdes; N O'Connor; J Wainscoat; G Pallesen; K Gatter; B Falini; G Delsol; H Lemke
Journal:  Blood       Date:  1985-10       Impact factor: 22.113

Review 9.  Adult systemic anaplastic large-cell lymphoma: recommendations for diagnosis and management.

Authors:  Nabila Bennani-Baiti; Stephen Ansell; Andrew L Feldman
Journal:  Expert Rev Hematol       Date:  2015-12-11       Impact factor: 2.929
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.